Clinical activity of antineoplastic drugs selected by tumor oligonucleotide expression microarrays (MP) in advanced and refractory cancer patients

Authors :: Pedro Bretcha
Manuel Sureda
Francisco J. Fernández-Morejón
Ramón González-Manzano
Francisco Fernández-Latorre
Elena Ma Martínez
Joseba Rebollo
Jesús Vegas
José Farré
Antonio Brugarolas
Source :: Journal of Clinical Oncology. 32:e22173-e22173
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: e22173 Background: MP is potentially useful for the sensitivity and resistance prediction to conventional and targeted drugs, although the wide number of platforms and algorithms used makes validat...

Subjects :: Cancer Research
Oncology
Oligonucleotide
business.industry
Cancer research
Antineoplastic Drugs
Medicine
DNA microarray
Bioinformatics
Refractory cancer
business

Full Text Access

Tools